ALB and COVID-19: Another recent systematic review and meta-analysis found that ischemic-modified albumin, a marker of oxidative injury, is elevated in COVID-19 patients, while total thiol levels are reduced, especially in critically ill cases, reinforcing redox imbalance as a disease-modifying axis (Mousavi et al., 2025).